Oklo Advances Groves 2 Forge Under DOE’s Nuclear Energy Launch Pad

  • Oklo selected for DOE’s Nuclear Energy Launch Pad to advance Groves 2 Forge, integrating isotope production and processing.
  • Groves 2 Forge will focus on lutetium-177 and other therapeutic isotopes for radiopharmaceutical treatments.
  • Project builds on Oklo’s Groves Isotope Test Reactor, which achieved criticality in under a year under DOE’s Reactor Pilot Program.
  • DOE’s Launch Pad initiative supports 12 developers across 13 projects for domestic reactor development and nuclear fuel cycle advancements.

Oklo’s selection for the DOE’s Nuclear Energy Launch Pad underscores the growing collaboration between private nuclear developers and federal agencies to advance domestic reactor technology. The initiative aims to address supply chain vulnerabilities in critical isotopes, particularly for medical applications, by integrating production and processing capabilities. This aligns with broader industry trends toward decentralized, modular nuclear solutions and highlights the strategic importance of securing domestic supply chains for essential materials.

Execution Risk
Whether Oklo can sustain the rapid development pace demonstrated with Groves Isotope Test Reactor.
Regulatory Dynamics
How DOE’s streamlined pathways for reactor development will impact commercialization timelines.
Market Impact
The pace at which U.S. isotope production capacity expands to reduce reliance on aging or foreign facilities.